Citalopram
- Product NDC
- 70518-2617
- 11-digit product format
- 705182617
- Labeler code
- 70518
- Product ID
- 70518-2617_dc64bb15-e3a0-fa5b-e053-2a95a90a4857
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077534
- Marketing category
- ANDA
- Marketing start
- 2020-03-09
- Marketing end
- 0000-00-00
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2617 | CITALOPRAM TABLET [REMEDYREPACK INC.] | 9 | Legacy NDC | 20250126_25b0d184-2a4c-42b0-9a57-7a00fa3e0cd7.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2617-0 | 70518261700 | 30 TABLET in 1 BLISTER PACK (70518-2617-0) | 30 tablet | 2020-03-09 | 0000-00-00 | No | No | Current |
| 70518-2617-1 | 70518261701 | 30 TABLET in 1 BLISTER PACK (70518-2617-1) | 30 tablet | 2021-06-17 | 0000-00-00 | No | No | Current |